Gupta S K, Veith F J
Montefiore Medical Center/Albert Einstein College of Medicine, New York, N.Y.
J Vasc Surg. 1990 Feb;11(2):348-56; discussion 356-7.
Prospective cost and reimbursement data were collected from 10 centers in various parts of the United States on 566 patients undergoing lower extremity arterial reconstructions for limb salvage and nonlimb salvage indications. Information for each patient was available on indication and type of procedure, length of stay, the type of hospital insurance, and hospital costs/charges. Diagnosis related group payments from each center were used to determine net gain or loss for each patient. Patients were classified as having claudication or critical ischemia (limb salvage). Reimbursements matched costs/charges for the claudication group; overall mean loss in this group was only $915 per patient. However, all centers had important losses in the limb salvage group. Reimbursements averaged 60% of costs/charges, with a mean loss of $8158 per patient and an overall loss for all 10 centers of $3,653,918. An effort to remedy this inequity is progressing via a dialogue between representatives of the Society for Vascular Surgery, the North American Chapter of the International Society for Cardiovascular Surgery, and the federal government.
前瞻性成本和报销数据收集自美国各地的10个中心,涉及566例因肢体挽救和非肢体挽救指征而接受下肢动脉重建手术的患者。每位患者的信息包括手术指征和类型、住院时间、医疗保险类型以及医院成本/收费。各中心的诊断相关组支付用于确定每位患者的净收益或损失。患者被分类为患有间歇性跛行或严重肢体缺血(肢体挽救)。报销金额与间歇性跛行组的成本/收费相匹配;该组每位患者的总体平均损失仅为915美元。然而,所有中心在肢体挽救组都有重大损失。报销平均为成本/收费的60%,每位患者平均损失8158美元,所有10个中心的总体损失为3653918美元。血管外科学会、国际心血管外科学会北美分会和联邦政府的代表正在通过对话努力纠正这种不公平现象。